Rochester Clinical Research is now enrolling adults 50-64 years old for a study evaluating an updated mRNA COVID-19 vaccine.
Covid-19 Vaccine
Age Range:
50 to 64
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This study will help researchers understand how safe the updated vaccine is and how well it protects against current variants of the virus.
The study lasts about 12 months and includes:
- 1 vaccination visit
- A few short follow-up visits or phone calls over the next year
Qualifications
You may qualify if you:
- Are between 50-64 years old
- Have not received a COVID-19 vaccine in the past 5 months
* Other Qualifications may apply
FEATURED STUDIES
Rochester Clinical Research is screening healthy adults ages 18 to 49 for an upcoming smallpox/mpox vaccine study at both our […]
Rochester Clinical Research is now enrolling adults 50-64 years old for a study evaluating an updated mRNA COVID-19 vaccine.
Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA). This study is enrolling […]
Rochester Clinical Research is actively recruiting participants aged 45+ for a clinical trial study testing an investigational medication designed to […]
Researchers are studying an investigational medication to see how effective it may be in slowing the Progression of Parkinson’s Disease. […]
We’re preparing for an upcoming research opportunity that may focus on people who smoke and are interested in learning more […]